Navigation Links
Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3
Date:8/24/2010

has recently initiated 12 weeks of dosing in a Phase 2b study, and PSI-938, an unpartnered guanosine nucleotide analog in a Phase 1 study. We also have in our pipeline an additional purine nucleotide analog, PSI-661, in advanced preclinical development. Racivir, for the treatment of HIV, has completed a Phase 2 clinical study.

Pegasys® and Copegus® are registered trademarks of Roche.ContactRichard E. T. Smith, Ph.D. VP, Investor Relations and Corporate Communicationsrichard.smith@pharmasset.comOffice: +1 (609) 613-4181Forward-Looking StatementsPharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:  Statements in this press release that are not historical facts are "forward-looking statements," including, without limitation, statements  that involve risks, uncertainties, and other important factors, including, without limitation,  the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates,  the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized.  For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2009 and our Quarterly Reports on Form 10-Q for the periods ended December 31, 2009, March 31, 2010 and June 30, 2010 filed with the Securities and Exchange Commission and disc
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... 1, 2015  For many businesses and industries just ... the case, having the right management software can be ... better than software solutions company TraxStar Technologies , ... the company announced the release of the newest version ... "QATrax ...
(Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
... , FRANKLIN LAKES, N.J., Dec. 29 ... matrix engineering, announced today that Dr. Shu-Tung Li, the ... as New Jersey,s 2009 Executive of the Year, an ... and Mattia, Certified Public Accountants and Consultants. In ...
... , , , , ... developer of medical device technology for the safe handling, ... Webinar program supporting its culture of safety initiative for ... Culture of Safety in Pharmacy: Lessons Learned," features an ...
Cached Medicine Technology:Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company 2Baxa Corporation to Sponsor Free Culture of Safety Webinar 2Baxa Corporation to Sponsor Free Culture of Safety Webinar 3
(Date:4/1/2015)... VA. (PRWEB) April 01, 2015 One year ... Warrior and Family Care Center in the United States and ... more than 16,000 square feet facility has served more than ... 50% of these visitors were wounded, ill and injured and ... of the nation’s largest military medical centers in the country. ...
(Date:4/1/2015)... Arroyo Grande, CA, March 24, 2015 (PRWEB) April 01, 2015 ... is considered by many, the most extreme jungle adventure you ... to as many as 23 days. Endorsed by the Philippine ... , ”Many people have visited the rainforest, but very few ... said Johan Bergman, Chief Adventure Officer. , Armed with nothing ...
(Date:4/1/2015)... DC (PRWEB) April 01, 2015 Taking ... the National League for Nursing Commission for Nursing ... Governors has approved the first NLN CNEA Board of ... RN, FAAN, ANEF, the 15-member board will provide leadership ... for overseeing all accreditation decisions for nursing programs that ...
(Date:4/1/2015)... Alexandria, VA (PRWEB) April 01, 2015 ... the College of American Pathologists (CAP), the Association ... of Clinical Oncology (ASCO) today released a draft ... of molecular marker testing for patients with primary ... help establish standard molecular marker testing, guide targeted ...
(Date:4/1/2015)... Vancouver, BC (PRWEB) April 01, 2015 ... recently announced that she is now offering her patients ... and services. Patients can participate in “Beauty Days”, which ... year by Dr Roz Kamani’s Kitsilano Skin Care Clinic. ... will directly tell patients about the latest products and ...
Breaking Medicine News(10 mins):Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 3Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 4Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 5Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2
... as good as invasive surgery in relieving painful symptoms ... is a painful condition of the wrist resulting from ... base of the palm up to the forearm affecting ... dental hygienists, and even golfers and tennis players. ...
... suffering from traumatic brain injuries shouldn’t receive steroids to ... patients who received the drugs to those who received ... for the study, results showed 21 percent of those ... of those who were not treated. According to Dr.Phil ...
... Genetic research has indeed unleashed several social and moral issues ... themselves.// However, it has also managed to shed new light ... announcement made by a U.S research team from the University ... understanding of genes which many think; may be connected ...
... more likely to kill high-risk women compared to women without ... recent study . ,8,353 women who had cardiovascular disease ... multiple risk factors were studied. The women were assessed for ... ,Researchers found only 7 percent of the women at ...
... adding radiation therapy to a treatment regimen already consisting ... better survival outcomes among women with high-risk breast cancer ... study done between 1979 and 1986, 318 patients were ... at all. In a 20-year follow-up, researchers found the ...
... researchers say obesity and weight gain may increase the ... causes increased urination of calcium and uric acid, resulting ... ,The association between the formation of kidney stones and ... was studied and results showed men who weighed more ...
Cached Medicine News:
... The DryEase Mini-Gel Drying System is a simple ... evaporation. The kit allows gels to be assembled ... both outer surfaces of the gels are exposed ... is minimized. The proprietary Gel-Dry™ Drying Solution modulates ...
... generations. Most gels can be dried by positioning ... gel dryer, covering them with wet semi-permeable cellophane ... the cellophane flat. Tut's Tombs also produce great ... somewhat larger than the gel to be dried. ...
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames....
Medicine Products: